PDCD1 and neoplasm: PD1, CTLA-4, LAG-3, TIM-3, and TIGIT are mainly T-cell surface proteins that serve as negative regulators for antitumor immunity, while PD-L1 is expressed on tumor cells serving as the ligand for PD1 [5].